Matches in SemOpenAlex for { <https://semopenalex.org/work/W2121570003> ?p ?o ?g. }
- W2121570003 endingPage "370" @default.
- W2121570003 startingPage "363" @default.
- W2121570003 abstract "Study Objectives The study objective was to identify changes in cystic fibrosis (CF) sputum microbiology over 13 years. Methods This study recruited a contemporary cohort of CF patients meeting similar eligibility criteria as the 520 subjects in the Phase 3 trials of inhaled tobramycin (historical cohort). Subjects submitted a single sputum specimen to a centralized laboratory for culture and susceptibility testing. Data were summarized and cross-sectional prevalence estimates were compared between cohorts. Exploratory analyses examined associations between recent antibiotic exposures and resistance prevalence. Results Sputum samples from 267 subjects from 33 US CF centers were submitted for testing. A total of 656 Pseudomonas aeruginosa isolates were identified from 253 culture-positive subjects. Comparison between cohorts revealed an increase in the prevalence of subjects with tobramycin resistant (11.8% vs. 30.4%, P < 0.001) and amikacin resistant (24.2% vs. 42.7%, P < 0.001) P. aeruginosa. Prevalence of ciprofloxacin resistance was similar (34.4% vs. 33.6%, P = 0.81). Within the contemporary cohort, potential associations between recent antibiotic exposures and prevalence of P. aeruginosa resistance were examined; findings included that exposure to intravenous carbapenems was significantly associated with aztreonam resistance, meropenem resistance, and multidrug resistance (P = 0.0002, P = 0.0003, and P = 0.0002, respectively). Prevalences of Staphylococcus aureus, methicillin-resistant S. aureus, Stenotrophomonas maltophilia, and Achromobacter xylosoxidans were also increased in the contemporary cohort. Conclusions We identified important changes in the patterns of CF airway microbiology, including increased aminoglycoside resistance and prevalence of other antibiotic resistant organisms. These changes are concerning to clinicians caring for individuals with CF because they impact treatment options. These data point to a critical need to develop new antimicrobials for CF. Pediatr Pulmonol. 2010; 45:363–370. © 2010 Wiley-Liss, Inc." @default.
- W2121570003 created "2016-06-24" @default.
- W2121570003 creator A5018301224 @default.
- W2121570003 creator A5019721018 @default.
- W2121570003 creator A5077615947 @default.
- W2121570003 creator A5085904604 @default.
- W2121570003 creator A5088080054 @default.
- W2121570003 date "2010-03-15" @default.
- W2121570003 modified "2023-10-16" @default.
- W2121570003 title "Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008" @default.
- W2121570003 cites W1969511733 @default.
- W2121570003 cites W1983262214 @default.
- W2121570003 cites W1987382652 @default.
- W2121570003 cites W1990987230 @default.
- W2121570003 cites W2032940647 @default.
- W2121570003 cites W2061571233 @default.
- W2121570003 cites W2088707861 @default.
- W2121570003 cites W2090652699 @default.
- W2121570003 cites W2096002246 @default.
- W2121570003 cites W2096675722 @default.
- W2121570003 cites W2096779618 @default.
- W2121570003 cites W2098093150 @default.
- W2121570003 cites W2113263701 @default.
- W2121570003 cites W2149276509 @default.
- W2121570003 cites W2163148714 @default.
- W2121570003 cites W2317332612 @default.
- W2121570003 doi "https://doi.org/10.1002/ppul.21198" @default.
- W2121570003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20232473" @default.
- W2121570003 hasPublicationYear "2010" @default.
- W2121570003 type Work @default.
- W2121570003 sameAs 2121570003 @default.
- W2121570003 citedByCount "112" @default.
- W2121570003 countsByYear W21215700032012 @default.
- W2121570003 countsByYear W21215700032013 @default.
- W2121570003 countsByYear W21215700032014 @default.
- W2121570003 countsByYear W21215700032015 @default.
- W2121570003 countsByYear W21215700032016 @default.
- W2121570003 countsByYear W21215700032017 @default.
- W2121570003 countsByYear W21215700032018 @default.
- W2121570003 countsByYear W21215700032019 @default.
- W2121570003 countsByYear W21215700032020 @default.
- W2121570003 countsByYear W21215700032021 @default.
- W2121570003 countsByYear W21215700032022 @default.
- W2121570003 countsByYear W21215700032023 @default.
- W2121570003 crossrefType "journal-article" @default.
- W2121570003 hasAuthorship W2121570003A5018301224 @default.
- W2121570003 hasAuthorship W2121570003A5019721018 @default.
- W2121570003 hasAuthorship W2121570003A5077615947 @default.
- W2121570003 hasAuthorship W2121570003A5085904604 @default.
- W2121570003 hasAuthorship W2121570003A5088080054 @default.
- W2121570003 hasConcept C126322002 @default.
- W2121570003 hasConcept C142724271 @default.
- W2121570003 hasConcept C2775832221 @default.
- W2121570003 hasConcept C2776301714 @default.
- W2121570003 hasConcept C2776352461 @default.
- W2121570003 hasConcept C2776938444 @default.
- W2121570003 hasConcept C2777181619 @default.
- W2121570003 hasConcept C2777427914 @default.
- W2121570003 hasConcept C2777637488 @default.
- W2121570003 hasConcept C2778512257 @default.
- W2121570003 hasConcept C2778974779 @default.
- W2121570003 hasConcept C2779375183 @default.
- W2121570003 hasConcept C2779631663 @default.
- W2121570003 hasConcept C2779912665 @default.
- W2121570003 hasConcept C2780416669 @default.
- W2121570003 hasConcept C2781069245 @default.
- W2121570003 hasConcept C501593827 @default.
- W2121570003 hasConcept C523546767 @default.
- W2121570003 hasConcept C54355233 @default.
- W2121570003 hasConcept C71924100 @default.
- W2121570003 hasConcept C72563966 @default.
- W2121570003 hasConcept C86803240 @default.
- W2121570003 hasConcept C89423630 @default.
- W2121570003 hasConcept C94665300 @default.
- W2121570003 hasConceptScore W2121570003C126322002 @default.
- W2121570003 hasConceptScore W2121570003C142724271 @default.
- W2121570003 hasConceptScore W2121570003C2775832221 @default.
- W2121570003 hasConceptScore W2121570003C2776301714 @default.
- W2121570003 hasConceptScore W2121570003C2776352461 @default.
- W2121570003 hasConceptScore W2121570003C2776938444 @default.
- W2121570003 hasConceptScore W2121570003C2777181619 @default.
- W2121570003 hasConceptScore W2121570003C2777427914 @default.
- W2121570003 hasConceptScore W2121570003C2777637488 @default.
- W2121570003 hasConceptScore W2121570003C2778512257 @default.
- W2121570003 hasConceptScore W2121570003C2778974779 @default.
- W2121570003 hasConceptScore W2121570003C2779375183 @default.
- W2121570003 hasConceptScore W2121570003C2779631663 @default.
- W2121570003 hasConceptScore W2121570003C2779912665 @default.
- W2121570003 hasConceptScore W2121570003C2780416669 @default.
- W2121570003 hasConceptScore W2121570003C2781069245 @default.
- W2121570003 hasConceptScore W2121570003C501593827 @default.
- W2121570003 hasConceptScore W2121570003C523546767 @default.
- W2121570003 hasConceptScore W2121570003C54355233 @default.
- W2121570003 hasConceptScore W2121570003C71924100 @default.
- W2121570003 hasConceptScore W2121570003C72563966 @default.
- W2121570003 hasConceptScore W2121570003C86803240 @default.
- W2121570003 hasConceptScore W2121570003C89423630 @default.
- W2121570003 hasConceptScore W2121570003C94665300 @default.